Table 2.
Specialties | N | Benefits and Risks of PA | PA assessment | PA prescription | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Pre | Post | Relative gain [95% CI] | Pre | Post | Relative gain [95% CI] | Pre | Post | Relative gain [95% CI] | ||
General | 349 | 71% | 85% | 26%*+ | 54% | 71% | 42%* | 67% | 88% | 45%* |
Practitioner | [21–30%] | [35–49%] | [37–52%] | |||||||
Family | 92 | 74% | 87% | 25%* | 54% | 73% | 59%* | 71% | 89% | 36%* |
Medicine | [15–35%] | [41–77%] | [23–49%] | |||||||
Internal | 194 | 75% | 85% | 22%*+ | 56% | 71% | 46%* | 73% | 88% | 30%+° |
Medicine | [15–29%] | [34–57%] | [22–38%] | |||||||
IM Sub. | 44 | 74% | 86% | 21%+ | 55% | 75% | 50%* | 74% | 88% | 24%+° |
[9–33%] | [28–72%] | [11–38%] | ||||||||
Pediatrics | 52 | 74% | 84% | 19%+ | 54% | 67% | 37% | 72% | 90% | 40%* |
[12–25%] | [21–52%] | [23–57%] | ||||||||
Cardiology | 59 | 64% | 75% | 24%*+ | 56% | 65% | 34% | 69% | 80% | 27% |
[15–34%] | [13–54%] | [10–44%] | ||||||||
Sports | 77 | 85% | 91% | 11%+ | 70% | 81% | 21%+ | 81% | 96% | 20%+ |
Medicine | [6–16%] | [11–31%] | [14–26%] | |||||||
Other | 177 | 66% | 83% | 39%* | 51% | 68% | 48%* | 65% | 88% | 47%* |
Specialties | [30–47%] | [37–60%] | [35–58%] | |||||||
Total | 1044 | 72% | 85% | 26% | 55% | 71% | 43% | 70% | 89% | 38% |
[23%–28%] | [39%–48%] | [34%–42%] |
*: Significantly higher than Sports medicine (p < 0.05)
+: Significantly lower than other (p < 0.05)
°: Significantly lower than General practitioners (p < 0.05)
IM Sub Internal medicine subspecialties others than Cardiology (immunology, endocrinology, pulmonology, nephrology, gastroenterology, hematology, intensive care specialists, and infectious diseases specialists)